Skip to content
Boost Up Blog – Lifestyle
Author:
Ovid Therapeutics Inc.
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
July 8, 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
June 4, 2026
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
June 3, 2026
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
April 8, 2026
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 18, 2026